SIRT2 and Sepsis: However, another study found that, in fatal septic shock mice models, AGK2 (a selective SIRT2 inhibitor) administration significantly improved the survival rate of mice and decreased sepsis-related “cytokine storm” coagulopathy disorders and bone marrow atrophy [47].